＜2023/R5＞
Shigeatsu Takamizawa, Junya Kojima, Tomohiro Umezu, Masahiko Kuroda, Shigehiro Hayashi, Takenori Maruta, Aikou Okamoto, Hirotaka Nishi.
miR‑146a‑5p and miR‑191‑5p as novel diagnostic marker candidates for ovarian clear cell carcinoma.
Mol Clin Oncol. 2023 Dec 28;20(2):14. doi: 10.3892/mco.2023.2712. eCollection 2024 Feb. Link　＞

＜2023/R5＞
Tomohiro Umezu, Shogo Tanaka, Shoji Kubo, Masaru Enomoto, Akihiro Tamori, Takahiro Ochiya, Y-h Taguchi, Masahiko Kuroda, Yoshiki Murakami.
Characterization of circulating miRNAs in the treatment of primary liver tumors.
Cancer Reports.

＜2023/R5＞
Kurata A, Harada Y, Fujita K, Ohno SI, Takanashi M, Yoshizawa S, Nagashima Y, Nagao T, Yamaguchi J, Kuroda M.
Smooth muscle differentiation of coronary intima in autopsy tissues after sirolimus-eluting stent implantation.
Cardiovasc Pathol. 2023 Sep-Oct;66:107554. doi: 10.1016/j.carpath.2023.107554. Epub 2023 Jun 13. Link　＞

＜2023/R5＞
Kosuke Oikawa, Masahiko Kuroda and Shogo Ehata.
Suppression of antitumor cytokine IL‑24 by PRG4 andPAI‑1 may promote myxoid liposarcoma cell survival.
Biomedical Reports 19(3): 60, Accepted June 27, 2023. doi: 10.3892/br.2023.1642. Link　＞

＜2023/R5＞
Shuya Matsubara, Akira Saito, Naoto Tokuyama, Ryu Muraoka, Takeshi Hashimoto, Naoya Satake, Toshitaka Nagao, Masahiko Kuroda & Yoshio Ohno.
Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features.
Scientific Reports volume 13, Article number: 11035 (Published 2023.July.7th) Link　＞